"Glioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Descriptor ID |
D005910
|
| MeSH Number(s) |
C04.557.465.625.600.380 C04.557.470.670.380 C04.557.580.625.600.380
|
| Concept/Terms |
Glioma- Glioma
- Gliomas
- Glial Cell Tumors
- Glial Cell Tumor
- Tumor, Glial Cell
- Tumors, Glial Cell
Mixed Glioma- Mixed Glioma
- Glioma, Mixed
- Gliomas, Mixed
- Mixed Gliomas
Malignant Glioma- Malignant Glioma
- Glioma, Malignant
- Gliomas, Malignant
- Malignant Gliomas
|
Below are MeSH descriptors whose meaning is more general than "Glioma".
Below are MeSH descriptors whose meaning is more specific than "Glioma".
This graph shows the total number of publications written about "Glioma" by people in this website by year, and whether "Glioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 4 | 4 | 8 |
| 1999 | 6 | 2 | 8 |
| 2000 | 6 | 0 | 6 |
| 2001 | 4 | 0 | 4 |
| 2002 | 6 | 1 | 7 |
| 2003 | 5 | 1 | 6 |
| 2004 | 2 | 0 | 2 |
| 2005 | 13 | 1 | 14 |
| 2006 | 5 | 1 | 6 |
| 2007 | 10 | 2 | 12 |
| 2008 | 3 | 0 | 3 |
| 2009 | 7 | 1 | 8 |
| 2010 | 10 | 0 | 10 |
| 2011 | 4 | 0 | 4 |
| 2012 | 7 | 2 | 9 |
| 2013 | 11 | 1 | 12 |
| 2014 | 8 | 3 | 11 |
| 2015 | 7 | 1 | 8 |
| 2016 | 17 | 0 | 17 |
| 2017 | 6 | 0 | 6 |
| 2018 | 7 | 2 | 9 |
| 2019 | 10 | 1 | 11 |
| 2020 | 4 | 1 | 5 |
| 2021 | 13 | 1 | 14 |
| 2022 | 7 | 0 | 7 |
| 2023 | 15 | 0 | 15 |
| 2024 | 3 | 0 | 3 |
| 2025 | 2 | 0 | 2 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glioma" by people in Profiles.
-
Intratumoral and intracranial hemorrhage associated with MAPK-pathway targeted therapy: a systematic review and mechanistic synthesis. J Neurooncol. 2026 Jul 15; 178(3).
-
Human neural organoid modeling of diffuse midline glioma captures the complexity of patient tumors. J Neurooncol. 2026 May 07; 177(3).
-
STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma model. J Clin Invest. 2026 Feb 16; 136(4).
-
Bi-specific T cell-engaging antibody triggers protective immune memory and glioma microenvironment remodeling in immune-competent preclinical models. J Immunother Cancer. 2025 Oct 28; 13(10).
-
Variability in radiotherapy outcomes across cancer types: a comparative study of glioblastoma multiforme and low-grade gliomas. Aging (Albany NY). 2025 02 27; 17(2):550-562.
-
The QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing Gliomas. Radiology. 2024 12; 313(3):e232555.
-
The impact of adjuvant radiotherapy on overall survival in spinal low-grade gliomas: a propensity score-matched analysis. J Neurooncol. 2025 Feb; 171(3):629-636.
-
Transcriptomic and proteomic spatial profiling of pediatric and adult diffuse midline glioma H3 K27-Altered. Sci Rep. 2024 09 30; 14(1):22668.
-
5-Aminolevulonic Acid, a New Tumor Contrast Agent: Anesthesia Considerations in Patients Undergoing Craniotomy. J Neurosurg Anesthesiol. 2024 Oct 01; 36(4):294-302.
-
Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30600.